Los Angeles Capital Management LLC Spero Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$12.22 - $15.79 $341,671 - $441,488	-27,960 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$13.23 - $21.48 $75,450 - $122,500	5,703 Added 25.62%	27,960 $411,000
Q4 2020 Feb 04, 2021	SELL	$11.65 - $22.07 $99,607 - $188,698	-8,550 Reduced 27.75%	22,257 $432,000
Q3 2020 Nov 02, 2020	SELL	$8.96 - $14.12 $46,529 - $73,325	-5,193 Reduced 14.43%	30,807 $344,000
Q2 2020 Aug 05, 2020	BUY	$7.27 - $14.18 $151,339 - $295,185	20,817 Added 137.11%	36,000 $487,000
Q1 2020 May 04, 2020	BUY	$5.27 - $10.41 $80,014 - $158,055	15,183 New	15,183 $123,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.